Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by TheeRookon Feb 05, 2021 3:21pm
211 Views
Post# 32486861

RE:VPT BOOSTERS IGNITED

RE:VPT BOOSTERS IGNITED But that alone will not move the SP.. Only Sales or a good investors relation company will.

VENTRIPOINT HIRES MARKETSMART COMMUNICATIONS TO PROVIDE INVESTOR RELATIONS SERVICES

Ventripoint Diagnostics Ltd. has entered into an investor relations agreement with MarketSmart Communications Inc. pursuant to which MarketSmart will provide investor relations (IR) services to Ventripoint. The IR agreement is for an initial term of six months commencing on Feb. 5 , 2021, with an option for renewal. Either party may terminate the agreement for any reason, with or without cause, on 15-day written notice to the other.

Pursuant to the IR agreement, MarketSmart will be paid a fee of $9,500 per month, plus applicable taxes, and will be granted stock options to purchase 400,000 common shares of Ventripoint at a price of 25 cents per share for a term of two years in accordance with the Ventripoint's stock option plan and vesting quarterly over one year

salstockpickz wrote:
great investment! great product! great managment! BY OUT around the corner, hold tight

GL longs



<< Previous
Bullboard Posts
Next >>